Form 4 Tracker
Rapport Therapeutics, Inc.
RAPP

40 insider filings · Latest: Oct 6, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Apr 8, 2026Apr 8 9:35 PMKRISHNASWAMY YELESWARAM
Proposed Sale
360$33.49$12.1K—

View →

Mar 30, 2026Mar 31 8:27 PMCheryl GaultChief Operating Officer
Sale
10,000$28.19$281.9K159,914(D)

View →

Mar 30, 2026Mar 30 9:31 PMCHERYL GAULT
Proposed Sale
10,000$27.84$278.4K—

View →

Mar 25, 2026Mar 26 8:41 PMKrishnaswamy YeleswaramChief Development Officer
Sale
10,115$29.99$303.4K286,876(D)

View →

Mar 25, 2026Mar 25 8:22 PMKRISHNASWAMY YELESWARAM
Proposed Sale
10,115$28.25$285.7K—

View →

Mar 5, 2026Mar 9 8:07 PMCheryl GaultChief Operating Officer
Sale
2,014$28.93$58.3K169,914(D)

View →

Mar 5, 2026Mar 5 10:54 PMGault Cheryl
Proposed Sale
2,014$28.92$58.2K—

View →

Feb 18, 2026Feb 20 12:06 AMAbraham CeesayDirector, Chief Executive Officer
Sale
10,916$29.35$320.4K20,729(I)

View →

Feb 17, 2026Feb 20 12:05 AMDavid BredtChief Scientific Officer
Sale
8,500$29.02$246.7K387,075(D)

View →

Jan 20, 2026Jan 23 12:00 AMAbraham CeesayDirector, Chief Executive Officer
Sale
10,916$26.11$285.1K25,812(I)

View →

Jan 15, 2026Jan 16 9:06 PMDavid BredtChief Scientific Officer
Sale
8,500$26.84$228.1K395,575(D)

View →

Jan 15, 2026Jan 15 9:28 PMDAVID BREDT
Proposed Sale
17,000$27.42$466.1K—

View →

Jan 2, 2026Jan 3 1:20 AMDAVID BREDT
Proposed Sale
6,567$30.05$197.3K—

View →

Jan 2, 2026Jan 3 1:17 AMKrishnaswamy Yeleswaram
Proposed Sale
2,840$30.05$85.3K—

View →

Dec 17, 2025Dec 17 9:28 PMTHE DOROTHY CEESAY IRREVOCABLE TRUST
Proposed Sale
15,249$30.76$469.1K—

View →

Dec 17, 2025Dec 17 9:25 PMABRAHAM CEESAY
Proposed Sale
17,499$30.76$538.3K—

View →

Oct 15, 2025Oct 15 8:26 PMDAVID BREDT
Proposed Sale
25,500$24.88$634.4K—

View →

Sep 17, 2025Sep 17 8:28 PMABRAHAM CEESAY
Proposed Sale
52,501$26.19$1.4M—

View →

Sep 17, 2025Sep 17 8:26 PMTHE DOROTHY CEESAY IRREV TRUST U/ADTD 03/27/2024
Proposed Sale
45,751$26.19$1.2M—

View →

Sep 8, 2025Sep 8 8:24 PMCHERYL GAULT
Proposed Sale
10,000$14.36$143.6K—

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 10, 2026Jun 10 9:57 PMJohn MaraganoreDirector
Grant/Award
15,200$35.2115,200(D)

View →

Jun 10, 2026Jun 10 9:52 PMRobert J PerezDirector
Grant/Award
15,200$35.2115,200(D)

View →

Jun 10, 2026Jun 10 9:46 PMSteven M PaulDirector
Grant/Award
15,200$35.2115,200(D)

View →

Jun 10, 2026Jun 10 9:28 PMPaul M SilvaDirector
Grant/Award
15,200$35.2115,200(D)

View →

Jun 10, 2026Jun 10 9:26 PMJames HealyDirector
Grant/Award
15,200$35.2115,200(D)

View →

Jun 10, 2026Jun 10 9:25 PMReid M HuberDirector
Grant/Award
15,200$35.2115,200(D)

View →

Jun 10, 2026Jun 10 9:24 PMWendy B. YoungDirector
Grant/Award
15,200$35.2115,200(D)

View →

Jun 10, 2026Jun 10 9:23 PMRamiro SanchezDirector
Grant/Award
15,200$35.2115,200(D)

View →

Feb 19, 2026Feb 20 12:05 AMDavid BredtChief Scientific Officer
Option Exercise
6,000$1.8088,080(D)

View →

Feb 2, 2026Feb 4 9:15 PMJeffrey SevignyChief Medical Officer
Grant/Award
130,000$27.75130,000(D)

View →

Feb 2, 2026Feb 4 9:14 PMAbraham CeesayDirector, Chief Executive Officer
Grant/Award
428,000$27.75428,000(D)

View →

Feb 2, 2026Feb 4 9:12 PMTroy A. IgnelziChief Financial Officer
Grant/Award
148,000$27.75148,000(D)

View →

Feb 2, 2026Feb 4 9:11 PMKrishnaswamy YeleswaramChief Development Officer
Grant/Award
120,000$27.75120,000(D)

View →

Feb 2, 2026Feb 4 9:09 PMDavid BredtChief Scientific Officer
Grant/Award
103,000$27.75103,000(D)

View →

Feb 2, 2026Feb 4 9:02 PMCheryl GaultChief Operating Officer
Grant/Award
132,000$27.75132,000(D)

View →